Akari Therapeutics, Plc (AKTX)

Akari Therapeutics, Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2.58	2.6	3.85	13.25	9.36	14.06
Cash & Short-Term Investments	2.58	2.6	3.85	13.25	9.36	14.06
Cash Growth	97.10%	-32.41%	-70.98%	41.54%	-33.40%	145.23%
Prepaid Expenses	0.63	0.09	0.3	0.47	2.17	0.29
Restricted Cash	0.06	0.06	-	-	-	-
Other Current Assets	0.08	0.2	0.2	0.1	0.09	0.23
Total Current Assets	3.35	2.95	4.34	13.82	11.63	14.58
Goodwill	8.43	8.43	-	-	-	-
Other Intangible Assets	39.18	39.18	0.01	0.02	0.02	0.03
Total Assets	50.96	50.56	4.36	13.83	11.65	14.6
Accounts Payable	13.07	12.41	1.67	0.95	1.79	3.38
Accrued Expenses	3.49	3.14	1.57	3.15	3.18	1.84
Short-Term Debt	1.85	3.26	-	-	-	-
Other Current Liabilities	2.5	1.11	1.35	7.95	1.12	-
Total Current Liabilities	20.91	19.91	4.58	12.04	6.09	5.22
Long-Term Deferred Tax Liabilities	8.04	8.04	-	-	-	-
Other Long-Term Liabilities	0.27	0.38	-	-	-	-
Total Liabilities	29.21	28.33	4.58	12.04	6.09	5.22
Common Stock	5.78	5.32	1.32	0.75	0.48	0.38
Additional Paid-In Capital	215.51	212.71	174.75	167.08	153.13	139.73
Retained Earnings	-250.96	-247.25	-227.46	-217.45	-199.71	-182.28
Comprehensive Income & Other	51.42	51.46	51.15	51.42	51.65	51.55
Shareholders' Equity	21.75	22.23	-0.23	1.79	5.55	9.38
Total Liabilities & Equity	50.96	50.56	4.36	13.83	11.65	14.6
Total Debt	1.85	3.26	-	-	-	-
Net Cash (Debt)	0.74	-0.66	3.85	13.25	9.36	14.06
Net Cash Growth	-43.82%	-	-70.98%	41.54%	-33.40%	145.23%
Net Cash Per Share	0.04	-0.06	0.79	4.24	4.36	8.90
Filing Date Shares Outstanding	32.18	28.88	7.92	5.06	2.97	1.92
Total Common Shares Outstanding	28.88	26.59	6.62	3.72	2.38	1.92
Working Capital	-17.56	-16.96	-0.24	1.77	5.53	9.36
Book Value Per Share	0.75	0.84	-0.03	0.48	2.33	4.88
Tangible Book Value	-25.86	-25.38	-0.24	1.77	5.53	9.36
Tangible Book Value Per Share	-0.90	-0.95	-0.04	0.48	2.32	4.86
Machinery	-	-	-	-	0.16	0.16

Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q